# Experimental Demo Risk Report

Last updated: 2026-06-08

Overall status: QUARANTINE_REVIEW_ONLY

## Current Risk Position

| Area | Status | Note |
| --- | --- | --- |
| Canonical Phase 2 readiness | FAIL | Measured-cost revalidation and assumption delta are FAIL. |
| Experimental executor | QUARANTINED | Broker-action code exists but is excluded from canonical Phase 2 authority. |
| Account whitelist | REQUIRED | Hardened executor refuses startup without whitelisted login. |
| Authorization token | REQUIRED | Hardened executor refuses startup without the experimental token. |
| Global caps | ACTIVE | Account-level daily order cap remains active; account-level open exposure cap was removed by owner request for the demo account. |
| Cost telemetry | ACTIVE | Order log now records spread/slippage/cost-R fields. |
| Same-family diversification | NOT CLAIMED | Same-family/provisional retest variants remain correlated. |

## Review Questions

Before continuing experimental demo execution, the owner/reviewer should answer:

```text
1. Which account login is whitelisted?
2. Which candidates are explicitly authorized?
3. What daily account-level order cap is acceptable?
4. Where is the kill-switch file placed?
5. Who reviews order logs daily?
6. What condition stops the experiment?
```

## Non-Authority Statement

This risk report does not approve Phase 2 paper mode, live trading, or real capital. It exists to keep the side experiment visible and reviewable while formal Phase 2 stays blocked.
